Literature DB >> 7191866

Cellular immune responses of mice to influenza virus vaccines.

C S Reiss, J L Schulman.   

Abstract

Parenteral sensitization of mice with equivalent amounts of untreated, gradient-purified or UV-inactivated influenza A/PR/8/34 virus (PR8 virus) results in the stimulation of maximal serum antibody titers, greatest numbers of antibody-forming cells (AFC), and strong virus-specific cytotoxic T lymphocyte (CTL) activity. In contrast, inoculation of formalin-inactivated virus, which induced antibody titers of equivalent magnitude, did not elicit a measurable primary CTL response nor prime for a secondary response. However, in mice previously exposed to untreated virus, challenge with formalin-inactivated virus evoked a secondary CTL response. Immunization of unprimed mice with aggregated viral glycoproteins or detergent-disrupted virus vaccine was much less immunogenic for antibody and AFC responses and did not evoke measurable primary, secondary, or memory cytotoxic effector cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7191866

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Influenza virus-infected epithelial cells present viral antigens to antigen-specific CD8+ cytotoxic T lymphocytes.

Authors:  H H Nguyen; P N Boyaka; Z Moldoveanu; M J Novak; H Kiyono; J R McGhee; J Mestecky
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Influenza virus-specific cytotoxic T-cell recognition: stimulation of nucleoprotein-specific clones with intact antigen.

Authors:  D C Wraith; A E Vessey
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

3.  Isotype profiles of anti-influenza antibodies in mice bearing the xid defect.

Authors:  M A Reale; C A Bona; J L Schulman
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

4.  Priming of virus-immune memory T cells in newborn mice.

Authors:  D H Schwartz; J L Hurwitz; N S Greenspan; P C Doherty
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

Review 5.  Some newly recognized aspects of resistance against and recovery from influenza.

Authors:  A Ennis
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  Capacity of influenza virus-monoclonal antibody mixtures to stimulate memory and cytotoxic T lymphocyte populations.

Authors:  N Greenspan; J L Hurwitz; P C Doherty
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

7.  Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin.

Authors:  Toshihiro Sawai; Yasushi Itoh; Hiroichi Ozaki; Norikazu Isoda; Kiyoko Okamoto; Yoshitaka Kashima; Yoshihiro Kawaoka; Yoshihiro Takeuchi; Hiroshi Kida; Kazumasa Ogasawara
Journal:  Immunology       Date:  2008-01-16       Impact factor: 7.397

8.  Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.

Authors:  Alaina J Mooney; Zhuo Li; Jon D Gabbard; Biao He; S Mark Tompkins
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

9.  Murine infection by vesicular stomatitis virus: initial characterization of the H-2d system.

Authors:  J M Forger; R T Bronson; A S Huang; C S Reiss
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

Review 10.  Development of stable influenza vaccine powder formulations: challenges and possibilities.

Authors:  J-P Amorij; A Huckriede; J Wilschut; H W Frijlink; W L J Hinrichs
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.